Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Sands Capital Alternatives, LLC 13F Holdings -- Portfolio & Top Positions (2026-03-31)

Sands Capital Alternatives, LLC (CIK 1846444) reported $421.2M across 20 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: NU ($93.9M, 22.30%), KVYO ($71.0M, 16.86%), ($64.8M, 15.38%), BBNX ($37.2M, 8.82%), IKT ($21.9M, 5.19%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1NUNU HLDGS LTD$93.9M22.30%6.5MTrimmed
2KVYOKLAVIYO INC$71.0M16.86%3.6MHold
3SPYGLASS PHARMA INC$64.8M15.38%2.5MNew
4BBNXBETA BIONICS INC$37.2M8.82%3.7MAdded
5IKTINHIBIKASE THERAPEUTICS INC$21.9M5.19%13.0MHold
6CPNGCOUPANG INC$19.1M4.54%1.0MAdded
7IOTSAMSARA INC$17.8M4.22%560,287Added
8DASHDOORDASH INC$16.7M3.97%111,231Added
9BIOABIOAGE LABS INC$13.8M3.27%786,353Hold
10TXG10X GENOMICS INC$10.2M2.43%481,770Hold
11DDOGDATADOG INC$10.1M2.40%85,793Hold
12ABOSACUMEN PHARMACEUTICALS INC$8.8M2.08%3.7MAdded
13TOSTTOAST INC$8.0M1.90%301,647Hold
14TARSTARSUS PHARMACEUTICALS INC$6.0M1.42%85,000Hold
15TTANSERVICETITAN INC$5.7M1.35%89,856Hold
16MNDYMONDAY COM LTD$4.7M1.11%67,868Hold
17TSHATAYSHA GENE THERAPIES INC$3.2M0.77%724,873Hold
18SNOWSNOWFLAKE INC$3.1M0.73%20,253Hold
19ACRVACRIVON THERAPEUTICS INC$3.0M0.70%2.1MHold
20CADLCANDEL THERAPEUTICS INC$2.0M0.47%405,837Hold
21FIGFIGMA INC$386,5660.09%18,286Hold

Source: SEC Form 13F filings · as of 2026-03-31